[1] SCHMIDT A E,SAHAI T,REFAAI M A,et al.Severe platelet transfusion refractoriness in association with antibodies against CD36[J]. Lab Med,2020,51(5):540-544. [2] FLESCH B K,SCHERER V,OPITZ A,et al.Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness[J]. Transfusion,2021,61(6):1932-1942. [3] 刘太香,马玲,梁文飚,等. 南京地区HPA、HLA已知基因型血小板供者资料库的建立与库容分析[J]. 中国输血杂志,2024,37(10):1126-1131. [4] 王仪含,何红红,金一鸣,等. 苏州地区献血者血小板HPA基因分型与CD36表型的研究[J]. 交通医学,2023,37(3): 296-299. [5] 刘静,徐秀章,丁浩强,等. 广州地区无偿献血者的CD36缺失频率及其分子基础研究[J]. 中国输血杂志,2018, 31(10):1132-1135. [6] 赵娜娜,王超,金惠新,等. 合肥地区无偿献血人群CD36抗原缺失的调查[J]. 临床输血与检验,2021,23(2):152-155. [7] 李大成,蓝欲晓,鲍自谦,等. 深圳地区无偿献血者群体CD36抗原缺失型的表型分析[J]. 中国输血杂志,2012, 25(4):304-307. [8] 卿芸,张涛,杨培,等. 重庆地区无偿献血者CD36抗原缺失的表型及基因型研究[J]. 中国输血杂志,2020,33(5):508-511. [9] LIU J,SHAO Y,DING H Q,et al.Distribution of CD36 deficiency in different Chinese ethnic groups[J]. Hum Immunol,2020,81(7):366-371. [10] MA C Y,WANG J H,YANG L,et al.A single-center investigational study of CD36 antigen deficiency and platelet alloantibody distribution in different populations in Northern China as well as platelet alloantibodies effect on pregnancy[J]. Clin Chim Acta,2019,498:68-75. [11] 李书平,魏习薇,李娜,等. 成都地区献血人群CD36基因突变频率的调查[J]. 中国输血杂志,2019,32(10):1034-1037. [12] OKAJIMA S,CHO K,CHIBA H,et al.Two sibling cases of Hydrops fetalis due to alloimmune anti-CD36 (Nak a) antibody[J]. Thromb Haemost,2006,95(2):267-271. [13] ROCK G,CLARK W,STERNBACH M,et al.Haemolytic uraemic syndrome is an immune-mediated disease:role of anti-CD36 antibodies[J]. Br J Haematol,2005,131(2): 247-252. [14] MORISHITA K,WAKAMOTO S,MIYAZAKI T,et al.Life-threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti-CD36 (Naka) isoantibody[J].Transfusion,2005,45(5):803-806. [15] WAKAMOTO S,FUJIHARA M,URUSHIBARA N, et al.Heterogeneity of platelet responsiveness to anti-CD36 in plasma associated with adverse transfusion reactions[J]. Vox Sang,2005,88(1):41-51. [16] 毛伟,蒋玉林,朱传福,等. 国内血小板基因库建设及应用的现状研究[J]. 临床输血与检验,2024,26(5):656-660. [17] 王嘉励,叶欣,丁浩强,等. 广州地区无偿献血者CD36基因突变的频率调查[J]. 中国免疫学杂志,2011,27(8):718-720. [18] 王超,吕蓉,胡晓玉,等. CD36抗原缺失Ⅰ型4种碱基突变及蛋白结构生物信息学分析[J]. 临床输血与检验,2024, 26(6):726-734. [19] KASHIWAGI H,TOMIYAMA Y,KOSUGI S,et al.Family studies of type Ⅱ CD36 deficient subjects:linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type Ⅱ CD36 deficiency[J]. Thromb Haemost,1995,74(2):758-763. [20] IMAI M,TANAKA T,KINTAKA T,et al.Genomic heterogeneity of type II CD36 deficiency[J]. Clin Chim Acta,2002,321(1/2):97-106. [21] XU X G,LIU Y,HONG X Z,et al.Variants of CD36 gene and their association with CD36 protein expression in platelets[J]. Blood Transfus,2014,12(4):557-564. [22] MASUDA Y,TAMURA S,MATSUNO K,et al.Diverse CD36 expression among Japanese population:defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal phenotype subjects[J]. Thromb Res,2015,135(5):951-957. [23] ALATTAR A G,STORRY J R,OLSSON M L.Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance[J]. Vox Sang,2024,119(5):496-504. [24] XU X Z,YE X,XIA W J,et al.Studies on CD36 deficiency in South China:two cases demonstrating the clinical impact of anti-CD36 antibodies[J]. Thromb Haemost,2013,110(6):1199-1206. [25] ZHOU Y,LI L L,ZHONG Z L,et al.Anti-CD36 mediated platelet transfusion refractoriness and related cases after stem cell transplantation[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi,2018,26(2):541-546. |